Lupus: The microbiome angle
- PMID: 29478734
- DOI: 10.1016/j.imbio.2017.11.004
Lupus: The microbiome angle
Abstract
Microbiota consists of more than 1014 microorganisms that inhabit different areas of the body including the gastrointestinal tract, mainly the mouth and gut. It includes viruses, fungi, protozoa, archaea and bacteria. The microbiota interacts closely with host leading to a dynamic relationship that results in the biological effects observed. Its diverse genetic material (microbiome) interacts closely with the host immune system and cells, and therefore is closely associated with inflammation, immune tolerance, adaptive immunity and autoimmune diseases. Bacterial microbiota, which is the mostly studied lives in harmony with the host and maintains a symbiotic relationship. Therefore it plays an important role in immunological, metabolic, and neurological aspects and thereby the well-being of the host. Alteration of the homeostatic environment or the dynamic balance of microorganisms can result in dysbiosis or disease. However, does dysbiosis cause disease, aggravate disease or is the result of the disease remains to be defined, it could be a bit of all three factors. More recently, a number of studies demonstrate that these microorganisms could contribute to disease. Alteration of the tightly balanced composition of bacterial microbiota (dysbiosis) leads to exacerbation, rapid progression and worsening of disease states. It is important to identify the 'healthy' microbes that maintain a healthy environment, the 'sensitive' microbes that go awry with disease, the 'bad' microbes that cause disease and the 'therapeutic' microbes that can help rectify the changes. Increased relative abundance of certain bacterial species has been linked to triggering autoimmune diseases. Despite the burgeoning literature in the field, the molecular mechanisms by which the microbiota impacts the body in health and disease remain largely unknown. In this review, we will discuss recent advancements in our understanding of the gut bacterial microbiota associated with inflammatory and immunological processes and the role they play in the autoimmune disease, systemic lupus erythematosus.
Keywords: Bacteria; Gut; Microbiome; Systemic lupus erythematosus.
Copyright © 2017 Elsevier GmbH. All rights reserved.
Similar articles
-
The role of gut microbiota in lupus: what we know in 2018?Expert Rev Clin Immunol. 2018 Oct;14(10):787-792. doi: 10.1080/1744666X.2018.1519395. Epub 2018 Sep 8. Expert Rev Clin Immunol. 2018. PMID: 30173572 Review.
-
The possible mechanisms of the human microbiome in allergic diseases.Eur Arch Otorhinolaryngol. 2017 Feb;274(2):617-626. doi: 10.1007/s00405-016-4058-6. Epub 2016 Apr 26. Eur Arch Otorhinolaryngol. 2017. PMID: 27115907 Review.
-
Intestinal dysbiosis in systemic lupus erythematosus: cause or consequence?Curr Opin Rheumatol. 2016 Sep;28(5):515-22. doi: 10.1097/BOR.0000000000000309. Curr Opin Rheumatol. 2016. PMID: 27466725 Review.
-
Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.Immunol Rev. 2017 Sep;279(1):70-89. doi: 10.1111/imr.12567. Immunol Rev. 2017. PMID: 28856738 Free PMC article. Review.
-
The microbiome and systemic lupus erythematosus.Immunol Res. 2017 Apr;65(2):432-437. doi: 10.1007/s12026-017-8906-2. Immunol Res. 2017. PMID: 28233089 Review.
Cited by
-
The Microbiome in Advanced Melanoma: Where Are We Now?Curr Oncol Rep. 2023 Sep;25(9):997-1016. doi: 10.1007/s11912-023-01431-3. Epub 2023 Jun 3. Curr Oncol Rep. 2023. PMID: 37269504 Free PMC article. Review.
-
The gut microbiome: what the oncologist ought to know.Br J Cancer. 2021 Oct;125(9):1197-1209. doi: 10.1038/s41416-021-01467-x. Epub 2021 Jul 14. Br J Cancer. 2021. PMID: 34262150 Free PMC article. Review.
-
Staphylococcus aureus Nasal Carriage and Autoimmune Diseases: From Pathogenic Mechanisms to Disease Susceptibility and Phenotype.Int J Mol Sci. 2019 Nov 11;20(22):5624. doi: 10.3390/ijms20225624. Int J Mol Sci. 2019. PMID: 31717919 Free PMC article. Review.
-
Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study.Exp Biol Med (Maywood). 2019 Apr;244(6):505-513. doi: 10.1177/1535370218818175. Epub 2018 Dec 12. Exp Biol Med (Maywood). 2019. PMID: 30539656 Free PMC article.
-
Changes in Gut Microbiota and Systemic Inflammation after Synbiotic Supplementation in Patients with Systemic Lupus Erythematosus: A Randomized, Double-Blind, Placebo-Controlled Trial.Cells. 2022 Oct 29;11(21):3419. doi: 10.3390/cells11213419. Cells. 2022. PMID: 36359816 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials